Moul JW - Search Results

1

Molecular Mechanisms of Castrate-Resistant Prostate Cancer.

Kotamarti S, Armstrong AJ, Polascik TJ, Moul JW. Kotamarti S, et al. Among authors: moul jw. Urol Clin North Am. 2022 Nov;49(4):615-626. doi: 10.1016/j.ucl.2022.07.005. Epub 2022 Oct 7. Urol Clin North Am. 2022. PMID: 36309418 Review.

2

Treatment of PSA only recurrence of prostate cancer after prior local therapy.

Moul JW. Moul JW. Curr Pharm Des. 2006;12(7):785-98. doi: 10.2174/138161206776056092. Curr Pharm Des. 2006. PMID: 16515495 Review.

3

Management of the patient with a rising PSA alone.

Moul JW, Ward JF. Moul JW, et al. Hematol Oncol Clin North Am. 2006 Aug;20(4):897-908. doi: 10.1016/j.hoc.2006.03.006. Hematol Oncol Clin North Am. 2006. PMID: 16861121 Review.

4

Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.

Moul JW, Sun L, Hotaling JM, Fitzsimons NJ, Polascik TJ, Robertson CN, Dahm P, Anscher MS, Mouraviev V, Pappas PA, Albala DM. Moul JW, et al. J Urol. 2007 Feb;177(2):499-503; discussion 503-4. doi: 10.1016/j.juro.2006.09.063. J Urol. 2007. PMID: 17222618

5

Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.

Sun L, Moul JW, Hotaling JM, Rampersaud E, Dahm P, Robertson C, Fitzsimons N, Albala D, Polascik TJ. Sun L, et al. Among authors: moul jw. BJU Int. 2007 Apr;99(4):753-7. doi: 10.1111/j.1464-410X.2006.06682.x. Epub 2007 Jan 19. BJU Int. 2007. PMID: 17244286

6

Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.

Mouraviev V, Nosnik I, Sun L, Robertson CN, Walther P, Albala D, Moul JW, Polascik TJ. Mouraviev V, et al. Among authors: moul jw. Urology. 2007 Feb;69(2):311-4. doi: 10.1016/j.urology.2006.10.025. Urology. 2007. PMID: 17320670

7

The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy.

Tseng TY, Cancel QV, Fesperman SF, Kuebler HR, Sun L, Robertson CN, Polascik TJ, Moul JW, Vieweg J, Albala DM, Dahm P. Tseng TY, et al. Among authors: moul jw. J Urol. 2007 Apr;177(4):1318-23. doi: 10.1016/j.juro.2006.11.035. J Urol. 2007. PMID: 17382723

8

Systemic strategies for prostate cancer.

Armstrong AJ, Febbo PG, George DJ, Moul J. Armstrong AJ, et al. Minerva Urol Nefrol. 2007 Mar;59(1):11-25. Minerva Urol Nefrol. 2007. PMID: 17431367 Review.

9

Timely diagnosis of testicular cancer.

Moul JW. Moul JW. Urol Clin North Am. 2007 May;34(2):109-17; abstract vii. doi: 10.1016/j.ucl.2007.02.003. Urol Clin North Am. 2007. PMID: 17484916 Review.

10

Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer.

Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ. Mouraviev V, et al. Among authors: moul jw. Cancer. 2007 Aug 15;110(4):906-10. doi: 10.1002/cncr.22858. Cancer. 2007. PMID: 17587207 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

510 results

Search Page